CATHY RUBEL: Open Payments
NPI 1568845782 · DEFIANCE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,466 in 102 payments from 13 companies in 2025. Trend: 2023 $1,403 · 2024 $1,800 · 2025 $1,466
Food & beverage: $1,466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $278 |
| Otsuka America Pharmaceutical, Inc. | 12 | $275 |
| Neurocrine BioSciences, Inc. | 15 | $153 |
| Axsome Therapeutics, Inc. | 13 | $138 |
| Vanda Pharmaceuticals Inc. | 6 | $119 |
| Alkermes, Inc. | 6 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
Products named: REXULTI, VRAYLAR, INGREZZA, Auvelity, FANAPT, ARISTADA, CAPLYTA, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
